Network Effects and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
33 Pages Posted: 7 Jul 1999 Last revised: 13 Mar 2022
Date Written: March 1999
Abstract
We examine the role of network effects in the demand for pharmaceuticals at both the brand level and for a therapeutic class of drugs. These effects emerge when use of a drug by others conveys information about its efficacy and safety to patients and physicians. This can lead to herd behavior where a particular drug -- not necessarily the most efficacious or safest -- can come to dominate the market despite the availability of close substitutes, and can also affect the rate of market diffusion. Using data for H2-antagonist antiulcer drugs, we examine two aspects of these effects. First, we use hedonic price procedures to estimate how the aggregate usage of a drug affects brand valuation. Second, we estimate discrete-time diffusion models at both the industry and brand levels to measure the impact on rates of diffusion and market saturation.
Suggested Citation: Suggested Citation
Do you have negative results from your research you’d like to share?
Recommended Papers
-
Higher Prices from Entry: Pricing of Brand-Name Drugs
By Jeffrey M. Perloff, Valerie Y. Suslow, ...
-
By Ernst R. Berndt, Linda Tm Bui, ...
-
Consumption Externalities and Diffusion in Pharmaceutical Markets: Antiulcer Drugs
By Ernst R. Berndt, Robert S. Pindyck, ...
-
Generic Drug Industry Dynamics
By David Reiffen and Michael R. Ward
-
Hedonic Analysis of Arthritis Drugs
By Iain M. Cockburn and Aslam H. Anis
-
Longer Patents for Increased Generic Competition: The Waxman-Hatch Act after One Decade
By Henry G. Grabowski and John M. Vernon